Fung MK, Eder AF, Spitalnik SL, Westhoff CM, Eds. Technical manual. 19th ed. Bethesda, MD: AABB Press, 2017.FungMKEderAFSpitalnikSLWesthoffCM, Eds. Technical manual. 19th ed.Bethesda, MD: AABB Press, 2017.Search in Google Scholar
Beattie K, Crawford M, Mallory D, Mougey R. Inhibition of blood group antibodies by soluble antigens. In: Mallory D, Ed. Immunohematology methods procedures. Washington, DC: American Red Cross, 1993, 31:1.BeattieKCrawfordMMalloryDMougeyR.Inhibition of blood group antibodies by soluble antigens. In: MalloryD, Ed. Immunohematology methods procedures. Washington, DC: American Red Cross, 1993, 31:1.Search in Google Scholar
Judd WJ, Johnson ST, Storry JR. Judd’s methods in Immunohematology. 3rd ed. Bethesda, MD: AABB Press, 2008.JuddWJJohnsonSTStorryJR.Judd’s methods in Immunohematology. 3rd ed.Bethesda, MD: AABB Press, 2008.Search in Google Scholar
Reid M, Lomas-Francis C, Olsson M. The blood group antigen factsbook. 3rd ed. San Diego, CA: Academic Press, 2012.ReidMLomas-FrancisCOlssonM.The blood group antigen factsbook. 3rd ed.San Diego, CA: Academic Press, 2012.10.1016/B978-0-12-415849-8.00026-0Search in Google Scholar
Seltsam A, Grueger D, Blasczyk R, Flegel WA. Easy identification of antibodies to high-prevalence Scianna antigens and detection of admixed alloantibodies using soluble recombinant Scianna protein. Transfusion 2009;49:2090–6.SeltsamAGruegerDBlasczykRFlegelWA.Easy identification of antibodies to high-prevalence Scianna antigens and detection of admixed alloantibodies using soluble recombinant Scianna protein. Transfusion2009;49:2090–6.10.1111/j.1537-2995.2009.02255.x531814419555420Search in Google Scholar
Anliker M, von Zabern I, Höchsmann B, et al. A new blood group antigen is defined by anti-CD59, detected in a CD59-deficient patient. Transfusion 2014;54:1817–22.AnlikerMvon ZabernIHöchsmannB, A new blood group antigen is defined by anti-CD59, detected in a CD59-deficient patient. Transfusion2014;54:1817–22.10.1111/trf.12531531720124383981Search in Google Scholar
Seltsam A, Wagner F, Lambert M, et al. Recombinant blood group proteins facilitate the detection of alloantibodies to high-prevalence antigens and reveal underlying antibodies: results of an international study. Transfusion 2014;54:1823–30.SeltsamAWagnerFLambertM, Recombinant blood group proteins facilitate the detection of alloantibodies to high-prevalence antigens and reveal underlying antibodies: results of an international study. Transfusion2014;54:1823–30.10.1111/trf.1255324635443Search in Google Scholar
Rojewski MT, Schrezenmeier H, Flegel WA. Tissue distribution of blood group membrane proteins beyond red cells: evidence from cDNA libraries. Transfus Apher Sci 2006, 35:71–82.RojewskiMTSchrezenmeierHFlegelWA.Tissue distribution of blood group membrane proteins beyond red cells: evidence from cDNA libraries. Transfus Apher Sci2006, 35:71–82.10.1016/j.transci.2006.05.00816956794Search in Google Scholar
Flegel WA, Henry SM. Can anti-A1 cause hemolysis? Transfusion 2018;58:3036–7.FlegelWAHenrySM.Can anti-A1 cause hemolysis?Transfusion2018;58:3036–7.10.1111/trf.14996628906630520091Search in Google Scholar
Morgan WTJ. The human ABO blood group substances. Experientia 1947;III:257–300.MorganWTJ.The human ABO blood group substances. Experientia1947;III:257–300.10.1007/BF0216416420269373Search in Google Scholar
Witebsky E, Klendshoj NC. The isolation of the blood group specific B substance. J Exp Med 1940;72:663–7.WitebskyEKlendshojNC.The isolation of the blood group specific B substance. J Exp Med1940;72:663–7.10.1084/jem.72.6.663213504319871051Search in Google Scholar
Grubb R. Correlation between Lewis blood group and secretor character in man. Nature 1948;162:933.GrubbR.Correlation between Lewis blood group and secretor character in man. Nature1948;162:933.10.1038/162933a018104581Search in Google Scholar
Moulds JM, Rowe KE. Neutralization of Knops system antibodies using soluble complement receptor 1. Transfusion 1996;36:517–20.MouldsJMRoweKE.Neutralization of Knops system antibodies using soluble complement receptor 1. Transfusion1996;36:517–20.10.1046/j.1537-2995.1996.36696269510.x8669083Search in Google Scholar
Wong SW. CD38 Monoclonal antibody therapies for multiple myeloma. Clin Lymphoma Myeloma Leuk 2015;15:635–45.WongSW.CD38 Monoclonal antibody therapies for multiple myeloma. Clin Lymphoma Myeloma Leuk2015;15:635–45.10.1016/j.clml.2015.07.64226443328Search in Google Scholar
Flegel WA, Chen Q, Castilho L, et al. Molecular immunohaematology round table discussions at the AABB annual meeting, Orlando 2016. Blood Transfus 2018;16:447–56.FlegelWAChenQCastilhoL, Molecular immunohaematology round table discussions at the AABB annual meeting, Orlando 2016. Blood Transfus2018;16:447–56.Search in Google Scholar
Tong B, Wang M. CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises. Future Oncol 2018;14:2179–88.TongBWangM.CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises. Future Oncol2018;14:2179–88.10.2217/fon-2018-003529667847Search in Google Scholar
Oostendorp M, Lammerts van Bueren JJ, et al. When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy. Transfusion 2015;55; 1555–62.OostendorpMLammerts van BuerenJJ, When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy. Transfusion2015;55; 1555–62.10.1111/trf.1315025988285Search in Google Scholar
Velliquette RW, Aeshlimann J, Kirkegaard J, Shakarian G, Lomas-Francis C, Westhoff CM. Monoclonal anti-CD47 interference in red cell and platelet testing. Transfusion 2019;59:730–7.VelliquetteRWAeshlimannJKirkegaardJShakarianGLomas-FrancisCWesthoffCM.Monoclonal anti-CD47 interference in red cell and platelet testing. Transfusion2019;59:730–7.10.1111/trf.1503330516833Search in Google Scholar
Judd WJ. Inhibition tests with soluble blood group substances. In: Judd WJ, Ed. Methods in immunohematology. 2nd ed. Durham, NC: Montgomery Scientific Publications, 1994;240.JuddWJ.Inhibition tests with soluble blood group substances. In: JuddWJ, Ed. Methods in immunohematology. 2nd ed.Durham, NC: Montgomery Scientific Publications, 1994;240.Search in Google Scholar
Seltsam A, Blasczyk R. Recombinant blood group proteins in clinical practice: from puzzling to binary antibody testing. ISBT Sci Ser 2016;11(Suppl 1):243–9.SeltsamABlasczykR.Recombinant blood group proteins in clinical practice: from puzzling to binary antibody testing. ISBT Sci Ser2016;11(Suppl 1):243–9.10.1111/voxs.12192Search in Google Scholar
Byrne KM, Sheldon SL, Flegel WA. Organization and management of an accredited specialist in blood bank (SBB) technology program. Transfusion 2010;50:1612–7.ByrneKMSheldonSLFlegelWA.Organization and management of an accredited specialist in blood bank (SBB) technology program. Transfusion2010;50:1612–7.10.1111/j.1537-2995.2010.02737.x339091221175473Search in Google Scholar
